Valuation: Abbott Laboratories

Market Cap 155B 135B 125B 116B 218B 14,884B 222B 1,493B 586B 7,288B 582B 569B 25,095B P/E 2026 *
22x
P/E 2027 * 18.8x
Enterprise Value 167B 146B 135B 124B 234B 16,006B 238B 1,605B 630B 7,838B 626B 612B 26,988B EV / Sales 2026 *
3.32x
EV / Sales 2027 * 2.99x
Free-Float
86.73%
Yield 2026 *
2.86%
Yield 2027 * 3.05%
1 day-3.42%
1 week-7.18%
Current month-1.96%
1 month+0.88%
3 months-11.96%
6 months-28.83%
Current year-29.00%
1 week 88.62
Extreme 88.62
94.98
1 month 87.21
Extreme 87.21
98.14
Current year 81.97
Extreme 81.97
129.46
1 year 81.97
Extreme 81.97
137.49
3 years 81.97
Extreme 81.97
141.23
5 years 81.97
Extreme 81.97
142.6
10 years 37.38
Extreme 37.38
142.6
Manager TitleAgeSince
Chief Executive Officer 52 31/03/2020
Director of Finance/CFO 53 01/09/2023
Chief Investment Officer 51 -
Director TitleAgeSince
Director/Board Member 64 09/12/2011
Director/Board Member 67 09/12/2011
Director/Board Member 71 16/02/2017
Date Insider Type Main position Quantity % Market Cap.
30/06Free

Director

416 0.0000%
30/06Free

Director

347 0.0000%
30/06Free

Director

432 0.0000%
Change 5-day change 1-year change 3-year change Capi.($)
-3.42%-7.18%-32.62%-17.58% 160B
-5.11%-5.40%-11.62%-9.53% 107B
-1.26%-0.72%+1.76%+57.91% 59.56B
-0.70%+6.17%+39.94%+55.69% 52.51B
-2.07%-3.61%-14.93%-41.92% 42.39B
-4.73%-10.11% - - 34.31B
-2.92%+0.75%-13.14%-46.02% 29.46B
-0.57%+0.44%+59.32%-7.14% 25.41B
-3.83%-3.09%-7.56%-8.88% 21.15B
-0.42%+5.13%-3.90%-18.19% 21B
Average -2.51%-2.08%+1.92%-3.96% 55.32B
Weighted average by Cap. -2.98%-3.65%-7.77%-2.60%

Financials

2026 *2027 *
Net sales 50.25B 43.91B 40.6B 37.51B 70.63B 4,827B 71.91B 484B 190B 2,363B 189B 185B 8,138B 54.74B 47.84B 44.22B 40.86B 76.94B 5,258B 78.33B 527B 207B 2,575B 206B 201B 8,865B
Net income 7.02B 6.13B 5.67B 5.24B 9.86B 674B 10.04B 67.61B 26.53B 330B 26.36B 25.78B 1,137B 8.39B 7.33B 6.78B 6.26B 11.79B 806B 12.01B 80.82B 31.71B 395B 31.51B 30.82B 1,359B
Net Debt 11.69B 10.22B 9.44B 8.72B 16.43B 1,123B 16.73B 113B 44.18B 550B 43.91B 42.94B 1,893B 8.84B 7.73B 7.14B 6.6B 12.43B 849B 12.65B 85.17B 33.42B 416B 33.21B 32.47B 1,432B
Logo Abbott Laboratories
Abbott Laboratories specializes in the research, development, manufacturing and marketing of pharmaceutical and medical products. Net sales break down by family of products as follows: - vascular devices (48.3%): endoprosthetic systems, dilation catheters, arterial closures, etc.; - diagnostic systems and instruments (20.2%); - nutrition products (19.1%): pediatric nutrition products, nutritional supplements, and dietetic products; - medicine (12.4%): anesthetics, antiviral products, antibiotics, inhibitors, anti-inflammatories, etc. Net sales are distributed geographically as follows: the United States (38.7%), Germany (6.2%), China (4.3%), India (4.2%), Switzerland (4.2%), Japan (3.3%), the United Kingdom (3%) and others (36.1%).
Employees
115,000
Date Price Change Volume
14/07/26 USD 88.96 -3.42% 12,472,237
13/07/26 USD 92.11 -1.94% 11,756,235
10/07/26 USD 93.93 -0.50% 6,913,069
09/07/26 USD 94.40 -0.82% 8,357,750
08/07/26 USD 95.18 -0.69% 10,102,295
Trader
Investor
Global
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
88.96USD
Average target price
116.40USD
Spread / Average Target
+30.85%

Quarterly revenue - Rate of surprise